Lymph node metastasis in melanoma: a debate on the significance of nodal metastases, conditional survival analysis and clinical trials

Mark B. Faries, Dale Han, Michael Reintgen, Lauren Kerivan, Douglas Reintgen, Corrado Caracò

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

While there is no doubt that regional lymph node metastases are an enormously important factor in melanoma staging and treatment, the biology behind this significance and its precise implications for treatment planning have been a leading controversy in melanoma and other solid tumors for over a century. Recent clinical data, including data from prospective randomized clinical trials have refined our understanding of the process of nodal metastases and the advantages and disadvantages of different clinical management strategies. This review presents two points of view in this debate and discusses the results of new data analyses as well as pivotal clinical trials informing the discussion.

Original languageEnglish (US)
Pages (from-to)431-442
Number of pages12
JournalClinical and Experimental Metastasis
Volume35
Issue number5-6
DOIs
StatePublished - Aug 1 2018
Externally publishedYes

Fingerprint

Survival Analysis
Melanoma
Lymph Nodes
Clinical Trials
Neoplasm Metastasis
Randomized Controlled Trials
Neoplasms

Keywords

  • Clinical trial
  • Lymphatic mapping
  • Melanoma
  • Sentinel lymph node
  • Surgical oncology

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Lymph node metastasis in melanoma : a debate on the significance of nodal metastases, conditional survival analysis and clinical trials. / Faries, Mark B.; Han, Dale; Reintgen, Michael; Kerivan, Lauren; Reintgen, Douglas; Caracò, Corrado.

In: Clinical and Experimental Metastasis, Vol. 35, No. 5-6, 01.08.2018, p. 431-442.

Research output: Contribution to journalArticle

Faries, Mark B. ; Han, Dale ; Reintgen, Michael ; Kerivan, Lauren ; Reintgen, Douglas ; Caracò, Corrado. / Lymph node metastasis in melanoma : a debate on the significance of nodal metastases, conditional survival analysis and clinical trials. In: Clinical and Experimental Metastasis. 2018 ; Vol. 35, No. 5-6. pp. 431-442.
@article{05fac10535d84557ac0479283c21f992,
title = "Lymph node metastasis in melanoma: a debate on the significance of nodal metastases, conditional survival analysis and clinical trials",
abstract = "While there is no doubt that regional lymph node metastases are an enormously important factor in melanoma staging and treatment, the biology behind this significance and its precise implications for treatment planning have been a leading controversy in melanoma and other solid tumors for over a century. Recent clinical data, including data from prospective randomized clinical trials have refined our understanding of the process of nodal metastases and the advantages and disadvantages of different clinical management strategies. This review presents two points of view in this debate and discusses the results of new data analyses as well as pivotal clinical trials informing the discussion.",
keywords = "Clinical trial, Lymphatic mapping, Melanoma, Sentinel lymph node, Surgical oncology",
author = "Faries, {Mark B.} and Dale Han and Michael Reintgen and Lauren Kerivan and Douglas Reintgen and Corrado Carac{\`o}",
year = "2018",
month = "8",
day = "1",
doi = "10.1007/s10585-018-9898-6",
language = "English (US)",
volume = "35",
pages = "431--442",
journal = "Clinical and Experimental Metastasis",
issn = "0262-0898",
publisher = "Springer Netherlands",
number = "5-6",

}

TY - JOUR

T1 - Lymph node metastasis in melanoma

T2 - a debate on the significance of nodal metastases, conditional survival analysis and clinical trials

AU - Faries, Mark B.

AU - Han, Dale

AU - Reintgen, Michael

AU - Kerivan, Lauren

AU - Reintgen, Douglas

AU - Caracò, Corrado

PY - 2018/8/1

Y1 - 2018/8/1

N2 - While there is no doubt that regional lymph node metastases are an enormously important factor in melanoma staging and treatment, the biology behind this significance and its precise implications for treatment planning have been a leading controversy in melanoma and other solid tumors for over a century. Recent clinical data, including data from prospective randomized clinical trials have refined our understanding of the process of nodal metastases and the advantages and disadvantages of different clinical management strategies. This review presents two points of view in this debate and discusses the results of new data analyses as well as pivotal clinical trials informing the discussion.

AB - While there is no doubt that regional lymph node metastases are an enormously important factor in melanoma staging and treatment, the biology behind this significance and its precise implications for treatment planning have been a leading controversy in melanoma and other solid tumors for over a century. Recent clinical data, including data from prospective randomized clinical trials have refined our understanding of the process of nodal metastases and the advantages and disadvantages of different clinical management strategies. This review presents two points of view in this debate and discusses the results of new data analyses as well as pivotal clinical trials informing the discussion.

KW - Clinical trial

KW - Lymphatic mapping

KW - Melanoma

KW - Sentinel lymph node

KW - Surgical oncology

UR - http://www.scopus.com/inward/record.url?scp=85047154623&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85047154623&partnerID=8YFLogxK

U2 - 10.1007/s10585-018-9898-6

DO - 10.1007/s10585-018-9898-6

M3 - Article

C2 - 29777421

AN - SCOPUS:85047154623

VL - 35

SP - 431

EP - 442

JO - Clinical and Experimental Metastasis

JF - Clinical and Experimental Metastasis

SN - 0262-0898

IS - 5-6

ER -